Pivotal Results of SELECT-MDS-1 Phase 3 Study of Tamibarotene with Azacitidine in Newly Diagnosed Higher-Risk MDS.
Amy E DeZern,Sylvain Thepot,Stéphane De Botton,Andrea Patriarca,Dries Deeren, Jose Miguel Torregrose Diaz,Giovanni Marconi, Teresa Bernal Del Castillo, Juan Miguel Bergua Burgues,Blanca Xicoy,Anna Jonasova, Amer M Zeidan, Sophie Dimicoli-Salazar,Célestine Simand,David Valcárcel,María Díez-Campelo, Wanxing Chai-Ho,Lalit Saini, Alice Garnier, Klaus Geissler,Yishai Ofran, Zsolt Nagy, Pramila Krishnamurthy,Michael Lübbert,Grzegorz W Basak,Hetty E Carraway,David A Sallman,Uma Borate,Valeria Santini, Victoria Campbell,Pierre Fenaux,Thorsten Braun, Francesco Lanza,Jan Maciej Zaucha,David A Roth, Sofia Paul, Pourab Roy, Michael Kelly,Angela Volkert, Jaime Chisolm, Tanya Abdul Malak, Virginia Klimek,Thomas Cluzeau Blood advances（2025）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper